Field Trip Health Ltd. (FTRP): Price and Financial Metrics
GET POWR RATINGS... FREE!
FTRP Stock Price Chart Interactive Chart >
FTRP Price/Volume Stats
|Current price||$0.85||52-week high||$6.41|
|Prev. close||$0.85||52-week low||$0.71|
|Day high||$0.85||Avg. volume||215,276|
|50-day MA||$0.83||Dividend yield||N/A|
|200-day MA||$1.86||Market Cap||49.43M|
Field Trip Health Ltd. (FTRP) Company Bio
Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
Most Popular Stories View All
FTRP Latest News Stream
|Loading, please wait...|
FTRP Latest Social Stream
View Full FTRP Social Stream
Latest FTRP News From Around the Web
Below are the latest news stories about Field Trip Health Ltd that investors may wish to consider to help them evaluate FTRP as an investment opportunity.
In a report released today, David Martin PhD from Bloom Burton maintained a Buy rating on Field Trip Health (FTRP – Research Report), with a price target of $9.50. The company's shares closed last Thursday at $1.59, close to its 52-week low of $1.51. According to TipRanks.com, PhD is ranked #659 out of 7805 analysts. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Field Trip Health with a $12.14 average price target, implying a 663.5% upside from current levels. In a report issued on February 2, Maxim Group also maintained a Buy rating on the stock with a $5.00 price target.
GAINERS: Mindset Pharma (OTC: MSSTF ) shares closed up 9.89% at $0.55 Small Pharma (OTC: DMTTF ) shares closed up 5.33% at $0.23 Intelgenx Technologies (OTC: IGXT ) shares closed up 1.06% at $0.32 LOSERS: ATAI Life Sciences (NASDAQ: ATAI ) shares closed down 8.49% at $5.71 Field Trip Health (NASDAQ: Full story available on Benzinga.com
Psychedelics-based company Field Trip Health Ltd. (TSX: FTRP) (NASDAQ: FTRP ) reported its third fiscal quarter 2022 results for the three months ended December 31, 2021 and provided a business update. Q3 Financial Highlights Patient services revenues totaled CA$1.4 million ($1.1 million) from its Toronto, New York, Santa Monica, Chicago, Atlanta, Houston, Fredericton, Seattle, San Diego and Amsterdam clinics, representing an increase of CA$1.04 million or 330% over the comparative quarter ended December 31, 2020 of $316,329 and an increase of $452,995 or 50% over the prior quarter. Net loss amounted to roughly CA$15 million, driven primarily by total operating costs, compared to CA$8.3 million in the corresponding quarter of fiscal … Full story available on Benzinga.com
No summary available.
Field Trip Health press release (NASDAQ:FTRP): FQ3 GAAP EPS of -$0.26 misses by $0.08. Revenue of $1.36M (+325.0% Y/Y) beats by $0.15M. Shares +1.16% AH....
FTRP Price Returns